231 related articles for article (PubMed ID: 16963208)
41. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
Abla N; Naik A; Guy RH; Kalia YN
J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
[TBL] [Abstract][Full Text] [Related]
42. In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement.
Li GL; van der Geest R; Chanet L; van Zanten E; Danhof M; Bouwstra JA
J Control Release; 2002 Nov; 84(1-2):49-57. PubMed ID: 12399167
[TBL] [Abstract][Full Text] [Related]
43. Correlation of transdermal iontophoretic phenylalanine and mannitol transport: test of the internal standard concept under DC iontophoresis and constant resistance AC iontophoresis conditions.
Yan G; Higuchi WI; Szabo A; Li SK
J Control Release; 2004 Jul; 98(1):127-38. PubMed ID: 15245895
[TBL] [Abstract][Full Text] [Related]
44. Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle.
Merclin N; Bramer T; Edsman K
J Control Release; 2004 Jul; 98(1):57-65. PubMed ID: 15245889
[TBL] [Abstract][Full Text] [Related]
45. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
Vemulapalli V; Yang Y; Friden PM; Banga AK
J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
[TBL] [Abstract][Full Text] [Related]
46. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
Altenbach M; Schnyder N; Zimmermann C; Imanidis G
Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
[TBL] [Abstract][Full Text] [Related]
47. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of iontophoretic transport of diphenhydramine hydrochloride thermosensitive gel by optimization of pH, polymer concentration, electrode design, and pulse rate.
Kotwal V; Bhise K; Thube R
AAPS PharmSciTech; 2007 Dec; 8(4):E120. PubMed ID: 18181541
[TBL] [Abstract][Full Text] [Related]
49. Transdermal macromolecular delivery: real-time visualization of iontophoretic and chemically enhanced transport using two-photon excitation microscopy.
Grewal BS; Naik A; Irwin WJ; Gooris G; de Grauw CJ; Gerritsen HG; Bouwstra JA
Pharm Res; 2000 Jul; 17(7):788-95. PubMed ID: 10990196
[TBL] [Abstract][Full Text] [Related]
50. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
[TBL] [Abstract][Full Text] [Related]
51. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
Nair A; Reddy C; Jacob S
Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
[TBL] [Abstract][Full Text] [Related]
52. Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
Drakulić BJ; Juranić IO; Erić S; Zloh M
Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333
[TBL] [Abstract][Full Text] [Related]
53. Drug release and its relationship with kinetic and thermodynamic parameters of drug sorption onto starch acetate fibers.
Xu W; Yang Y
Biotechnol Bioeng; 2010 Mar; 105(4):814-22. PubMed ID: 19882717
[TBL] [Abstract][Full Text] [Related]
54. A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis.
Saluja S; Kasha PC; Paturi J; Anderson C; Morris R; Banga AK
Int J Pharm; 2013 Sep; 453(2):395-9. PubMed ID: 23735902
[TBL] [Abstract][Full Text] [Related]
55. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
[TBL] [Abstract][Full Text] [Related]
56. Iontophoretic drug delivery system: a review.
Semalty A; Semalty M; Singh R; Saraf SK; Saraf S
Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833
[TBL] [Abstract][Full Text] [Related]
57. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
58. Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.
Nugroho AK; Della-Pasqua O; Danhof M; Bouwstra JA
Pharm Res; 2005 Mar; 22(3):335-46. PubMed ID: 15835738
[TBL] [Abstract][Full Text] [Related]
59. Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system.
Teksin ZS; Hom K; Balakrishnan A; Polli JE
J Control Release; 2006 Nov; 116(1):50-7. PubMed ID: 17049402
[TBL] [Abstract][Full Text] [Related]
60. In vitro drug release mechanism and drug loading studies of cubic phase gels.
Lara MG; Bentley MV; Collett JH
Int J Pharm; 2005 Apr; 293(1-2):241-50. PubMed ID: 15778062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
